3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
75
HER2-positive Breast Cancer
10
Neoplasms
8
Neoplasm Metastasis
4
Colonic Neoplasms
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Prostatic Neoplasms
3
Multiple Myeloma
3
Hematologic Neoplasms
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Anatomic Stage I Breast Cancer AJCC v8
3
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Rectal Neoplasms
2
Pathologic Complete Response
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Inflammatory Breast Neoplasms
2
HER2-positive Early Breast Cancer
2
Colorectal Neoplasms
2
Breast Diseases
2
Biliary Tract Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Interventions
Exercise
55
Resistance Training
9
Nutritional Status
6
Control Groups
5
Surveys and Questionnaires
4
Standard of Care
4
Diet
4
Preoperative Exercise
3
Nutrition Assessment
3
Methods
3
High-Intensity Interval Training
3
Counseling
3
lime
2
Vitamin D
2
Physical Therapy Modalities
2
Palliative Care
2
Interviews as Topic
2
Exercise Therapy
2
Exercise Test
2
Dosage Forms
2
Diet Therapy
2
Blood Specimen Collection
2
pembrolizumab
1
diacetamate
1
cytisine
1
cemiplimab
1
beta-Glucans
1
avelumab
1
YES1 protein, human
1
Whey Proteins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Motor Activity
×
pertuzumab
×
1 year
×
Clear all
No trials found.